Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$6.56 - $10.95 $960,738 - $1.6 Million
146,454 New
146,454 $1 Million
Q4 2022

Feb 13, 2023

BUY
$14.33 - $18.37 $211,410 - $271,012
14,753 New
14,753 $232,000
Q3 2021

Nov 15, 2021

SELL
$13.38 - $18.8 $387,685 - $544,730
-28,975 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$17.08 - $29.6 $1.91 Million - $3.31 Million
-111,880 Reduced 79.43%
28,975 $509,000
Q1 2021

May 17, 2021

SELL
$5.86 - $27.73 $479,306 - $2.27 Million
-81,793 Reduced 36.74%
140,855 $3.55 Million
Q4 2020

Feb 16, 2021

BUY
$2.65 - $7.61 $590,017 - $1.69 Million
222,648 New
222,648 $1.44 Million

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $139M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.